Back

Serum Tumor Marker Profiles in Interstitial Lung Diseases: Implications for Differential Diagnosis and Disease Severity Assessment

2026-01-16 respiratory medicine Title + abstract only
View on medRxiv
Show abstract

BackgroundInterstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF) and connective tissue disease-associated ILD (CTD-ILD), share similar features that complicate diagnosis. Tumor markers are often elevated in ILD, yet their diagnostic utility remains unclear. MethodsThis retrospective study included ILD patients hospitalized between 2018 and 2025. Serum levels of alpha-fetoprotein, carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 199, CA125, CA153, neuron-specif...

Predicted journal destinations